[go: up one dir, main page]

MX2007004040A - Uso para alfa-simpatomimeticos con estructura de 2-imidazolina. - Google Patents

Uso para alfa-simpatomimeticos con estructura de 2-imidazolina.

Info

Publication number
MX2007004040A
MX2007004040A MX2007004040A MX2007004040A MX2007004040A MX 2007004040 A MX2007004040 A MX 2007004040A MX 2007004040 A MX2007004040 A MX 2007004040A MX 2007004040 A MX2007004040 A MX 2007004040A MX 2007004040 A MX2007004040 A MX 2007004040A
Authority
MX
Mexico
Prior art keywords
sympathomimetics
novel use
imidazoline structure
imidazoline
preventing
Prior art date
Application number
MX2007004040A
Other languages
English (en)
Inventor
Fritz Sacher
Marion Tschaikin
Stephan Koelsch
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35276675&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2007004040(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of MX2007004040A publication Critical patent/MX2007004040A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invencion se refiere al uso de simpatomimeticos que tienen una estructura de 2-imidazolina para la preparacion de un medicamento para la profilaxis y / o tratamiento de enfermedades virales.
MX2007004040A 2004-10-05 2005-09-16 Uso para alfa-simpatomimeticos con estructura de 2-imidazolina. MX2007004040A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004049008A DE102004049008A1 (de) 2004-10-05 2004-10-05 Neue Verwendung für α-Sympathomimetika mit 2-Imidazolinstruktur
PCT/EP2005/010026 WO2006037452A1 (de) 2004-10-05 2005-09-16 NEUE VERWENDUNG FÜR α-SYMPATHOMIMETIKA MIT 2-IMIDAZOLINSTRUKTUR

Publications (1)

Publication Number Publication Date
MX2007004040A true MX2007004040A (es) 2007-05-24

Family

ID=35276675

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007004040A MX2007004040A (es) 2004-10-05 2005-09-16 Uso para alfa-simpatomimeticos con estructura de 2-imidazolina.

Country Status (20)

Country Link
US (1) US20080108685A1 (es)
EP (1) EP1802302B1 (es)
JP (1) JP5311825B2 (es)
KR (1) KR20070059134A (es)
CN (1) CN101022797B (es)
AU (1) AU2005291603B2 (es)
BR (1) BRPI0516832A (es)
CA (1) CA2582984C (es)
CY (1) CY1118581T1 (es)
DE (1) DE102004049008A1 (es)
DK (1) DK1802302T3 (es)
ES (1) ES2612544T3 (es)
HU (1) HUE031515T2 (es)
LT (1) LT1802302T (es)
MX (1) MX2007004040A (es)
PL (1) PL1802302T3 (es)
PT (1) PT1802302T (es)
RU (1) RU2397764C2 (es)
WO (1) WO2006037452A1 (es)
ZA (1) ZA200703622B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004049008A1 (de) 2004-10-05 2006-04-06 Merck Patent Gmbh Neue Verwendung für α-Sympathomimetika mit 2-Imidazolinstruktur
US12343427B1 (en) * 2024-04-23 2025-07-01 Nivagen Pharmaceuticals, Inc. Stable intravenous diltiazem hydrochloride formulation and use thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0661967B1 (en) 1991-11-19 1999-08-25 University Of Virginia Patent Foundation Combined virustatic antimediator (covam) treatment of common colds
JPH06211659A (ja) * 1993-01-19 1994-08-02 Kowa Co 点鼻薬組成物
US5576437A (en) * 1993-12-17 1996-11-19 The Procter & Gamble Company 7-(2-imidazolnylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists
DE4438589A1 (de) 1994-10-28 1995-03-23 Reingard Dr Muenster Nasentherapeutikum
WO1996025163A1 (en) * 1995-02-14 1996-08-22 Board Of Supervisors Or Louisiana State Universityof Agricultural And Mechanical College Through Itsmedical Center Treatment of herpes simplex viruses
US5916900A (en) * 1995-06-29 1999-06-29 The Procter & Gamble Company 7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists
DE19541919C2 (de) 1995-11-10 1997-11-20 Klosterfrau Mcm Vetrieb Gmbh Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
EP0903151A1 (en) 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
AU2001294808A1 (en) * 2000-09-29 2002-04-08 Board Of Trustees Operating Michigan State University Catecholamine pharmaceutical compositions and methods
PL208686B1 (pl) 2001-09-18 2011-05-31 Nycomed Danmark Aps Kompozycja w postaci roztworu wodnego do leczenia przeziębienia oraz zastosowanie połączenia ipratropium lub jego soli i ksylometazoliny lub jej soli
RU2220739C1 (ru) * 2002-08-30 2004-01-10 Гапонюк Петр Яковлевич Интраназальное средство
DE10250944B9 (de) 2002-10-31 2004-09-16 Cell Center Cologne Gmbh Verwendung eines Stifts zur Applikation von Pflege- oder Wirkstoffen in die Nase
DE102004049008A1 (de) 2004-10-05 2006-04-06 Merck Patent Gmbh Neue Verwendung für α-Sympathomimetika mit 2-Imidazolinstruktur

Also Published As

Publication number Publication date
CY1118581T1 (el) 2017-07-12
CN101022797A (zh) 2007-08-22
PL1802302T3 (pl) 2017-08-31
CA2582984A1 (en) 2006-04-13
ZA200703622B (en) 2008-08-27
CN101022797B (zh) 2010-12-15
EP1802302B1 (de) 2016-10-26
BRPI0516832A (pt) 2008-09-23
AU2005291603B2 (en) 2010-10-14
DE102004049008A1 (de) 2006-04-06
AU2005291603A1 (en) 2006-04-13
JP2008515824A (ja) 2008-05-15
RU2397764C2 (ru) 2010-08-27
JP5311825B2 (ja) 2013-10-09
US20080108685A1 (en) 2008-05-08
PT1802302T (pt) 2017-02-07
DK1802302T3 (en) 2017-02-06
EP1802302A1 (de) 2007-07-04
CA2582984C (en) 2012-06-05
KR20070059134A (ko) 2007-06-11
HUE031515T2 (en) 2017-07-28
RU2007116719A (ru) 2008-11-20
LT1802302T (lt) 2017-02-10
WO2006037452A1 (de) 2006-04-13
ES2612544T3 (es) 2017-05-17

Similar Documents

Publication Publication Date Title
AP2212A (en) Phosphonates, Monophosphonamidates, Bisphosphonamidates for the treatment of viral diseases.
LT2878297T (lt) Medikamentai, skirti fibrozinių ligų gydymui arba prevencijai
WO2007127263A3 (en) Therapeutic uses of urolithins
MY151020A (en) Transdermal therapeutic system
IL180872A0 (en) Substituted 8-aminoalkylthio-xanthines, and the use thereof as inhibitors of the dipeptidyl peptidase iv
ATE461217T1 (de) Glp-1-verbindungen
SG149063A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
TW200738270A (en) Method of treating depression using a TNFα antibody
MX2010006204A (es) Derivados de oxindol 5,6-disubstituidos y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina.
MX2007002470A (es) Fenilaminotiazoles sustituidos y su uso.
AU2003258145A8 (en) Substituted phenylindoles for the treatment of hiv
TWI372056B (en) Novel medicament combinations for the treatment of respiratory diseases
WO2003039539A3 (de) Verwendung von endothelin-rezeptor-antagonisten zur behandlung von tumorerkrankungen
MX2007000224A (es) Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de nauseas y vomitos.
UA97401C2 (ru) Экструдат с улучшенной маскировкой вкуса
ES1053382Y (es) Protesis dilatadora del vestibulo nasal.
TW200740429A (en) Methods and dosage forms for reducing side effects of carbamate compounds
MXPA05001885A (es) El uso de una combinacion de ciclesonida y antihistaminas para el tratamiento de la rinitis alergica.
UA96926C2 (ru) Применение sdf-1 для лечения и/или профилактики неврологических заболеваний
UA88655C2 (ru) S-миртазапин для лечения прилива крови
MXPA04003910A (es) Uso de irbesartan para la preparacion de medicamentos que son utiles para la prevencion o tratamiento de hipertension pulmonar.
GB0410238D0 (en) Therapeutic agents
MY140538A (en) Substituted n-acyl-2-aminothiazoles
MX2007004040A (es) Uso para alfa-simpatomimeticos con estructura de 2-imidazolina.
GB2443377A (en) Anti-malarial composition comprising artesunate and lumefantrine

Legal Events

Date Code Title Description
FG Grant or registration